CVS Health Reports Record Fourth Quarter And Full Year Results For 2016; Confirms 2017 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to CVS Health Reports Record Fourth Quarter And Full Year Results For 2016; Confirms 2017 EPS Guidance
February 10, 2017 8:51 AM EST
UBS analyst Michael Cherny reiterates Buy rating and raises price target on CVS Health Corp. (NYSE: CVS) to $89 (from $88.50), suggesting the companys continued PBM net new business is offset by ongoing weakness in retail.
Cherny comments, "CVS 4Q had a number of... More
February 9, 2017 12:11 PM EST
Evercore ISI lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.50) while maintaining a Buy rating. The analyst said management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates.
Analyst Ross Muken commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below dollar profit... More
February 9, 2017 6:56 AM EST
CVS Health (NYSE: CVS) reported Q4 EPS of $1.71, $0.04 better than the analyst estimate of $1.67. Revenue for the quarter came in at $46 billion versus the consensus estimate of $46.5 billion.
Net revenues increased 11.7% to $46.0 billionOperating profit in line with Company\'s expectationsGAAP...
More
